News

Monday, 26 November 2018

New device could monitor anticoagulant treatments to deliver personalised therapies

Researchers from CSIC, ICN2 and CIBER-BBN have designed a biosensor device based on gold nanostructures that precisely detects the presence of anticoagulant drug from a small blood sample. Treatments with anticoagulants such as Sintrom® (acenocoumarol) face the difficulty of adjusting the drug doses. This device will allow patients to self-regulate the dose.

Wednesday, 14 November 2018

BrainCom, the story of collaboration across fields

Imagine you wanted to build a device that could allow people with severe speech impairment to engage in everyday conversation. How would you go about it? Coordinator of the European BrainCom project, ICREA Prof. Jose A. Garrido talks us through the process of building the right team.